304.5 Understanding response rates of electronic PROMs in clinical care: trends and characteristics Margot de Jong 1 , Sabine Super 1 , Anouk Groenewegen 2 , Harm Gijsbers 3 , Maud van Muilekom 2 , Hedy van Oers 2 , Lotte Haverman 2 , Nynke Venema-Taat 1 1 Amsterdam Public Health, Digital Health, Amsterdam, Netherlands, 2 Department of Child and Adolescent Psychiatry and Psychosocial Care, Amsterdam UMC, University of Amsterdam, Emma Childrens Hospital, Amsterdam, The Netherlands, 3 Amsterdam UMC location University of Amsterdam, Department of Medical Informatics, eHealth Living & Learning Lab Amsterdam, Amsterdam, The Netherlands Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :304.5 Aims Using Patient Reported Outcome Measures (PROMs) on an individual level in clinical care have been shown to enhance patient-clinician communication, improve quality of life and even increase survival
Nutrition: Keep protein intake adequate and overall diet balanced to support metabolism and lean mass
The mean follow-up was 4.81.1 years for the GLP-1RAs group and 4.91.9 years for the second- or third-line glucose-lowering medications group
Berbeda dengan Semaglutide yang bekerja pada reseptor GLP-1 saja, Tirzepatide bekerja pada: GLP-1 GIP (Glucose-Dependent Insulinotropic Polypeptide) Karena bekerja pada dua jalur hormonal sekaligus, Tirzepatide sering disebut sebagai dual agonist
Commercial / Employer Group & marketplace plans UPMC Health Plan is a Pennsylvania provider-sponsored insurer with commercial, Medicare, Medicaid, and ACA exchange lines
